We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 198

Dear doctor letters as the next warning frontier Kapps vs. Winter

  • Dechert LLP
  • -
  • USA
  • -
  • October 28 2011

Under the learned intermediary rule, for a warning claim to succeed, at a bare minimum the prescribing (or sometimes another) doctor at least has to read the allegedly defective warning

Medical device preemption developments

  • Dechert LLP
  • -
  • USA
  • -
  • January 11 2012

Boring title, but accurate

Tallying TwIqbal

  • Dechert LLP
  • -
  • USA
  • -
  • December 2 2011

It’s been a while since we’ve taken a comprehensive look at how TwIqbal’s been affecting prescription medical product liability pleading

Guest post - never odd or even, just preempted

  • Dechert LLP
  • -
  • USA
  • -
  • January 31 2012

Oh wait a minute

Mass tort program changes Philadephia CCP

  • Dechert LLP
  • -
  • USA
  • -
  • February 16 2012

We were going to blog about something else today, but we received what Judge Herron of the Philadelphia Court of Common Pleas has entitled “General Court Regulation No. 2012-01 In re: Mass Tort and Asbestos Programs”

Another win for removal before service

  • Dechert LLP
  • -
  • USA
  • -
  • May 2 2012

We’ve learned of another win for removal before service in our local federal court, the Eastern District of Pennsylvania

A grab bag of Daubert rulings in a remanded ArediaZometa case

  • Dechert LLP
  • -
  • USA
  • -
  • March 15 2011

We have reported periodically on rulings in the ArediaZometa litigation, including Daubert and summary judgment rulings by the MDL judge and choice of law rulings by Judge Arthur Spatt of the E.D.N.Y. in Deutsch v. Novartis Pharmaceuticals Corp., a case remanded for trial from the MDL

GSK citizenship issue on appeal

  • Dechert LLP
  • -
  • USA
  • -
  • April 6 2012

We can’t say much of substance about this issue, as we represent GlaxoSmithKline in certain matters, but a remedy is in sight (we hope) for the peculiar situation that has developed with respect to GSK’s citizenship for purposes of diversity jurisdiction

Depositions - when can you talk to your own witness?

  • Dechert LLP
  • -
  • USA
  • -
  • February 10 2011

We had the issue of when a lawyer can, and can't, confer with hisher own witness during a deposition come up recently in one of our cases

Off-label uses held "medically accepted" as a matter of law

  • Dechert LLP
  • -
  • USA
  • -
  • March 18 2011

Could the FDA prosecute a drug manufacturer for sending a copy of a judicial opinion to its customers?